C1 possessed more mutations in three well‐known tumor suppressors including TP53 and BAP1, while C2 possessed more mutations in genes CTNNB1, APOB1, and EEF1A1 (Figure 3d). This evidence concerns the gene CTNNB1 and neoplasm.